Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Simei, Ren"'
Autor:
Hongwei Peng, Zhangren Chen, Yunyun Wang, Simei Ren, Tiantian Xu, Xin Lai, Jinhua Wen, Mengjun Zhao, Chuanfei Zeng, Lijuan Du, Yanmei Zhang, Li Cao, Jinfang Hu, Xiaohua Wei, Tao Hong
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
COVID-19 has been announced pandemic by WHO and over 17,000,000 people infected (Till April 21st 2020). The disease is currently under control in China, with a curative rate of 86.8%. Chloroquine (CQ) is an old anti-malarial drug with good tolerabili
Externí odkaz:
https://doaj.org/article/ac493640b55243f88011bd4899fae0e1
Autor:
Peng Yang, Cui Shujuan, Luyao Long, Tingting Yuan, Simei Ren, Quanyi Wang, Daitao Zhang, Yang Pan
Publikováno v:
Clinical Chemistry
Background Coronavirus disease-2019 (COVID-19) has spread widely throughout the world since the end of 2019. Nucleic acid testing (NAT) has played an important role in patient diagnosis and management of COVID-19. In some circumstances, thermal inact
Publikováno v:
Journal of Cancer
Background: Lung cancer is the most common cause of death from cancer worldwide and recent studies have revealed that microRNAs play critical roles to regulate lung carcinogenesis. microRNA-129-5p (miR-129-5p) has been reported to regulate cell proli
Publikováno v:
Annals of clinical and laboratory science. 51(3)
MicroRNAs (miRNAs) have been confirmed to play an essential role in modulating cancer cell proliferation, metastasis, and sensitivity to chemotherapy. However, the correlation between miR-132-3p expression and etoposide (VP16) induced apoptosis in hu
Autor:
Simei Ren, Zhe-Sheng Chen, Yehuda G. Assaraf, Luyao Long, Zi-Ning Lei, Hongwei Peng, Lin Yang
Publikováno v:
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy. 52
Acute myeloid leukemia (AML) is a highly aggressive hematological malignancy with complex heterogenous genetic and biological nature. Thus, prognostic prediction and targeted therapies might contribute to better chemotherapeutic response. However, th
Publikováno v:
Clinical Laboratory. 66
Background Cyclosporine injection is usually applied in allogeneic hematopoietic stem cell transplantation (Allo-HSCT) during induction phase. Anaphylaxis to cyclosporine injection is rare and how to deal with this issue in clinical practice is intra
Autor:
Youchun Wang, Sanlong Wang, Shuya Zhou, Xi Wu, Xue Wang, Simei Ren, Li Qianqian, Guitao Huo, Ming Guo, Qin Zuo, Yuelei Shen, Jianjun Lyu, Yanan Guo, Qingfen Zhu, Yanwei Yang, Baowen Li, Fan Changfa, Susu Liu
Publikováno v:
Oncotarget.
// Changfa Fan 1, * , Jianjun Lyu 2, * , Susu Liu 1, * , Xi Wu 1 , Qianqian Li 2 , Shuya Zhou 1 , Yanwei Yang 2 , Guitao Huo 2 , Qin Zuo 1 , Qingfen Zhu 3 , Ming Guo 3 , Simei Ren 4 , Yanan Guo 5 , Sanlong Wang 2 , Baowen Li 1 , Xue Wang 2 , Yuelei S
Publikováno v:
Clinical laboratory. 62(10)
BACKGROUND In EQA schemes, results are usually assessed against a target value. METHODS Outliers in each result were deleted using a robust statistical method. Mean was used as a target value if trimmed results were normally distributed; otherwise, m
Publikováno v:
Cytometry Part A. 85:231-241
Cell surface proteins play an important role in multidrug resistance (MDR). However, the identification involving chemoresistant features for cell surface proteins is a challenge. To identify potential cell membrane markers in hematologic cancer MDR,
Publikováno v:
Clinical Laboratory; Mar2020, Vol. 66 Issue 3, p477-480, 4p